Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.SummaryDifference2%
- Check22 days agoChange Detected- Terminology updated: 'Clear cell renal carcinoma' replaced with 'Clear cell carcinoma of kidney'. - Version bumped from v3.0.2 to v3.1.0.SummaryDifference0.2%
- Check37 days agoChange DetectedRevision bumped from v3.0.1 to v3.0.2; the 'Back to Top' link was removed, a minor UI change.SummaryDifference0.2%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, and a 'Back to Top' feature has been added.SummaryDifference0.2%
- Check51 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various proteins and antibodies, while removing several related medical topics and terms.SummaryDifference2%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.